- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 39/385 - Haptens or antigens, bound to carriers
Patent holdings for IPC class A61K 39/385
Total number of patents in this class: 2163
10-year publication summary
|
151
|
152
|
150
|
125
|
163
|
144
|
135
|
128
|
155
|
106
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Glaxosmithkline Biologicals S.A. | 1601 |
90 |
| Pfizer Inc. | 3384 |
49 |
| The Regents of the University of California | 20720 |
37 |
| Northwestern University | 3540 |
23 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2999 |
22 |
| Selecta Biosciences, Inc. | 171 |
21 |
| The University of British Columbia | 1537 |
20 |
| Merck Sharp & Dohme LLC | 3735 |
20 |
| Wyeth LLC | 608 |
18 |
| Children's Medical Center Corporation | 1956 |
18 |
| Deutsches Krebsforschungszentrum Stiftung des Offentlichen Rechts | 400 |
18 |
| Ecole Polytechnique Federale de Lausanne (epfl) | 1608 |
17 |
| SK Bioscience Co., Ltd. | 127 |
16 |
| The Trustees of the University of Pennsylvania | 4414 |
14 |
| UTi Limited Partnership | 459 |
14 |
| The Scripps Research Institute | 1343 |
13 |
| The Regents of the University of Michigan | 4979 |
12 |
| President and Fellows of Harvard College | 6091 |
12 |
| Sanofi Pasteur Inc. | 285 |
12 |
| Curevac SE | 293 |
12 |
| Other owners | 1705 |